Og'irlikni yo'qotish yo'g'on ichak va to'g'ri ichak poliplari xavfini kamaytirish bilan bog'liq

Ushbu xabarni baham ko'ring

May 2022: According to study findings published February 1 in the Journal of the National Cancer Institute, overweight or obese adults who lose more than 5 pounds over five years have a 46 percent lower risk of developing precancerous colon polyps, which are benign growths in the colon or rectum that can lead to colorectal cancer.

Tana vazni va yo'g'on ichak saratoni

From 1993 to 2001, researchers examined the relationship between weight change and colon and rectal polyps in 18,588 men and women who took part in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening study. People who have self-reported their weight three times during the course of their lives were included in the study. The case group included 1,053 people who acquired polyps three to five years into the study, while the control group included those who did not. Those who dropped weight throughout early to late adulthood had a much lower risk of having polyps than those who maintained their weight, especially if they were initially overweight (had a BMI of more than 25). People who gained weight during the trial, on the other hand, had a 1.3 times higher risk of getting polyps. In comparison to women, the link appeared to be stronger in men.

Researchers have discovered for the first time that limiting weight gain during adulthood lowers the risk of acquiring precancerous growths that can lead to kolorektal saraton. The advantages appear to be linked to being overweight or obese.

Bizning xabarnomamizga obuna bo'ling

Yangilanishlarni oling va Cancerfax blogini hech qachon o'tkazib yubormang

Ko'proq o'rganish uchun

Insonga asoslangan CAR T hujayra terapiyasi: yutuqlar va muammolar
CAR T-Cell terapiyasi

Insonga asoslangan CAR T hujayra terapiyasi: yutuqlar va muammolar

Insonga asoslangan CAR T-hujayra terapiyasi saraton hujayralarini nishonga olish va yo'q qilish uchun bemorning o'z immun hujayralarini genetik jihatdan o'zgartirish orqali saraton kasalligini davolashda inqilob qiladi. Tananing immun tizimining kuchini ishga solgan holda, bu muolajalar saratonning har xil turlarida uzoq muddatli remissiya potentsialiga ega kuchli va moslashtirilgan davolash usullarini taklif qiladi.

Sitokinlarni ajratish sindromini tushunish: sabablari, belgilari va davolash
CAR T-Cell terapiyasi

Sitokinlarni ajratish sindromini tushunish: sabablari, belgilari va davolash

Sitokinlarni chiqarish sindromi (CRS) - bu immunoterapiya yoki CAR-T hujayra terapiyasi kabi ba'zi davolash usullari bilan qo'zg'atiladigan immunitet tizimining reaktsiyasi. Bu sitokinlarning haddan tashqari chiqarilishini o'z ichiga oladi, bu isitma va charchoqdan tortib organlarning shikastlanishi kabi hayot uchun xavfli asoratlargacha bo'lgan alomatlarni keltirib chiqaradi. Boshqaruv ehtiyotkorlik bilan monitoring va aralashuv strategiyasini talab qiladi.

Yordam kerak? Bizning jamoamiz sizga yordam berishga tayyor.

Yaqiningiz va yaqinlaringizning tezroq sog'ayib ketishini tilaymiz.

Suhbatni boshlang
Biz onlaynmiz! Biz bilan suhbatlashing!
Kodni skanerlang
Salom,

CancerFax-ga xush kelibsiz!

CancerFax ilg'or bosqich saratoniga duchor bo'lgan shaxslarni CAR T-Cell terapiyasi, TIL terapiyasi va butun dunyo bo'ylab klinik sinovlar kabi ilg'or hujayra terapiyalari bilan bog'lashga bag'ishlangan kashshof platformadir.

Siz uchun nima qilishimiz mumkinligini bizga xabar bering.

1) Chet elda saraton kasalligini davolash?
2) CAR T-hujayrali terapiya
3) Saratonga qarshi emlash
4) Onlayn video konsultatsiya
5) Proton terapiyasi